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Abstract
Background: The incidence of a peri-implant soft tissue dehiscence/deficiency
(PSTD) is not a rare finding. Despite multiple previous attempts aimed at correcting
the PSTDs, a classification of these conditions has not yet been proposed. This lack
in the literature may also lead to discrepancies in the reported treatment outcomes
and thus misinform the clinician or the readers. The aim of the present article was
therefore to present a classification of peri-implant PSTD at a single implant site.
Methods: Four classes of PSTDs were discussed based on the position of the gingival
margin of the implant-supported crown in relation to the homologous natural tooth.
In addition, the bucco-lingual position of the implant head was also taken into con-
sideration. Each class was further subdivided based on the height of the anatomical
papillae.
Results: Subsequently, for each respective category a surgical approach (including
bilaminar techniques, the combined prosthetic-surgical approach or soft tissue aug-
mentation with a submerged healing) was also suggested.
Conclusion: This paper provides a new classification system for describing PSTDs
at single implant sites, with the appropriate recommended treatment protocol.
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1 INTRODUCTION
The predictability of dental implants in replacing missing
teeth has been extensively demonstrated.1,2 The success in
implant therapy, however, should not be solely dependent on
its long-term survival, but also on its functional, esthetic,
hard- and soft-tissue stability, as well as patient-reported
outcomes.3,4 Indeed, over the years patients’ esthetic demands
have increased such that even a minimal apical shift of the gin-
gival margin revealing the greyish color of the implant may be
considered unacceptable, especially in the esthetic region.5
An apical shift of the peri-implant facial soft tissue mar-
gin has been defined with many terms throughout the lit-
erature, including mid-facial recession, mucosal recession
or dehiscence, soft-tissue dehiscence/deficiency or a soft-
tissue defect.6 As these complications can manifest either
as mucosal recessions (apical shifting of the peri-implant
mucosal margin), or only a greyish hue noticeable through
the mucosa, and/or discrepancies in the length of the implant-
supported crown (compared with the homologous natural
tooth), the term peri-implant soft tissue dehiscence/deficiency
(PSTD) may be the most appropriate for their description.6
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Regarding its prevalence, a peri-implant PSTD is not a rare
finding. In a 2-year prospective study, Bengazi et al. reported a
57% incidence of PSTD ≥1 mm (on the facial or lingual sites)
during the first 6 months. Interestingly, the authors found
no further progression in the following months.7 Small and
Tarnow, based on a noticeable trend of PSTD occurrence in
1 year, concluded that 1 mm of PSTD can be expected within
3 months from the implant-abutment connection.8
Among the factors that can lead to a mucosal recession,
Lin et al. proposed that lack of or a minimal keratinized
mucosa around implants may play a crucial role.9 According
to a systematic review by Chen and Buser, immediately
placed implants are associated with a higher risk of facial
PSTD (from 9% to 41%),10 possibly due to the insufficient
experience of the surgeon or (site specific) anatomical
limitations.11,12 In this view, Evans and Chen also discovered
a significantly greater apical shift of the soft tissue margin
in patients with a thin biotype.13 Additionally, they also
highlighted the importance of the position of the implant
shoulder, which correlated with a three times greater risk
of producing PSTD if buccally placed, compared with
a lingually positioned one.13 Cosyn and colleagues, in
line with the previous finding, discovered an odds ratio
of 17.2 for mid-facial PSTD and a buccally positioned
implant.14
The relatively high prevalence of a midfacial PSTD that can
range up to 64% in immediate implants,15 can be attributed to
many predisposing and precipitating factors including: a buc-
cally positioned implant, an osseous dehiscence or fenestra-
tion at the buccal bone, a thin gingival biotype, a lack of or a
minimal keratinized mucosa, vigorous tooth brushing, inflam-
mation, and an over contoured prosthesis.16 While some of
these factors are also present in the case of gingival recessions
around natural teeth,16 for PSTD to occur around implants it
is believed that among all the predisposing factors, the bucco-
lingual positioning of the fixture is the most crucial causative
factor.13,14
The peri-implant mucosa also significantly differs from the
periodontal soft tissue. Indeed, the long junctional epithelium,
the parallel organization of the connective tissue fibers, the
lower number of fibroblasts, and reduced vascularity which
are characteristic of the peri-implant soft tissue, are more sim-
ilar to a scar tissue than the soft tissue around teeth.17,18 These
anatomical differences may lead to an inferior PSTD coverage
compared with the outcomes usually obtained when treating
teeth with the same technique.19
Therefore, a classification of PSTDs around implants can-
not be based on the conventional methods used for grading
gingival recessions.20,21 Indeed, a PSTD should not only be
defined based on the interproximal attachment level,21 rather
the position and the extension of the PSTD, the height of
the papillae, and the level of the implant-supported crown
margin in relation to the contralateral or adjacent teeth and
the bucco-lingual position of the implant should also be taken
into account.
The primary aim of treating PSTD should include the
complete coverage of the dehiscence along with the re-
establishment of the soft tissue margin (and the crown margin)
at the same level of the homologous tooth.6 Many techniques,
such as the coronally advanced flap (CAF),19,22 the tunnel,23
the VISTA technique,24 free gingival grafts,25 guided bone
regeneration procedures,26 resubmergence technique,27,28 or
a surgical-prosthetic approach29 have been proposed for
treating PSTDs.
It may be reasonable to assume that the variability in the
obtained outcomes, such as a vast difference in mean PSTD
coverage (from 40% to 66% in some trial,19,22 to 90% to 96%
in others5,29) does not only depend on the surgical approach,
but also on the case selection. Thus, it is crucial to presurgi-
cally differentiate the types of PSTDs introducing a classifi-
cation of these conditions.
2 MATERIALS AND METHODS
2.1 Proposed classification of peri-implant
soft tissue dehiscence/deficiencies
The proposed classification focuses on PSTDs on the facial
site of a single implant in the esthetic zone (excluded molar
teeth) not affected by peri-implant diseases, with an attempt
to suggest a decision-making process for selecting the most
appropriate treatment protocol to achieve an ideal esthetic
outcome. In agreement with the 2017 World Workshop,30 in
the absence of baseline radiographs, implants showing signs
of inflammation on gentle probing, probing depth ≥6 mm,
and bone levels ≥3 mm apical of the most coronal portion
of the intra-osseous part of the implant are considered to be
affected by a peri-implant disease and therefore are excluded
from the present classification. However, in the presence of
previous examination data, a peri-implant disease is defined
based on presence of bleeding on probing, increasing probing
depth compared with previous examinations, and the presence
of radiographic bone loss beyond crestal bone level changes
resulting from initial remodeling.30
Hence, the following classification of PSTD was formu-
lated:
• Class I. The soft tissue margin is located in an estheti-
cally correct position (at the same level of the ideal position
of the gingival margin of the homologous natural tooth),
and the color of the abutment/implant is visible only
through the mucosa and/or there is a lack of keratinized tis-
sue/soft tissue thickness (Figs. 1A through 1C)
• Class II. The soft tissue margin is located more api-
cal to the ideal position of the gingival margin of the
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F I G U R E 1 A Frontal, B occlusal, and C lateral view of PSTD Class I. This class is characterized by an esthetically correct position of the soft
tissue margin which is at the same level of the gingival margin of the homologous natural tooth, however the color of the abutment/implant is visible
through the mucosa. D Frontal, E occlusal view, and F, schematic drawings of PSTD Class II. This class is characterized by a soft tissue margin
which is located more apical to the ideal position of the gingival margin and the implant-supported crown profile is located inside the imaginary
curve line that connects the profile of the adjacent teeth at the level of the soft tissue margin
homologous natural tooth and the implant-supported crown
profile is located inside (more palatal) the imaginary curve
line that connects the profile of the adjacent teeth at the level
of the soft tissue margin (Figs. 1D through 1F)
• Class III and IV. The soft tissue margin is located more
apical to the ideal position of the gingival margin of the
homologous natural tooth and the implant-supported crown
profile is located outside (more facial to) the imaginary
curve line that connects the profile of the adjacent teeth
at the level of the soft tissue margin. In these classes it is
mandatory to remove the implant-supported crown. When
the head of the implant is inside (more palatal or at the
level of) the straight imaginary line that connects the pro-
file of the adjacent teeth at the level of the gingival margin,
the PSTD is defined as Class III (Fig. 2), while when the
implant head is outside (more facial) this imaginary line,
this is referred to as Class IV (Fig. 3).
Each of the classes (except for Class I where subgroup c
is not clinically detectable) can be further subdivided into the
following subcategories in relation to the papilla dimension:
• a: when the tip of both papillae is ≥3 mm coronal to the
ideal position of soft tissue margin of the implant-supported
crown (Fig. 4A)
• b: when the tip of at least one papilla is at a distance <3 mm
coronal to the ideal position of the soft tissue margin of the
implant supported crown (Fig. 4B).
• c: when the height of at least one papilla is at the same level
or more apical of the ideal position of the soft tissue margin
of the implant-supported crown (Fig. 4C).
Table 1 depicts the proposed classification of PSTD.
3 RESULTS
3.1 Recommended treatment protocol for
each PSTD type
A summary of the treatment approaches proposed in the lit-
erature for the management of PSTD and their reported out-
comes is depicted in Supplementary Data S1 in online Journal
of Periodontology.
A PSTD of Class I is not a deficiency in the apico-coronal
dimension but in the thickness/amount of keratinized mucosa
that allows for the appearance of the greyish color of the
implant components. In presence of adequate papillae
dimension, a CAF or a tunnel procedure with the addition
of a connective tissue graft (CTG) or soft tissue substitutes
(e.g., dermal matrix) is therefore the treatment of choice for
managing this condition. If one papilla is <3 mm in height
(subclass b), it is recommended to remove the implant-
supported crown and modify the abutment to increase the
interproximal soft tissue and therefore increase the vascular
supply for the CAF + CTG. A PSTD of Class I subgroup c is
not clinically detectable.
A Class II PSTD can be treated with CAF + CTG when
the tips of both papillae are at least 3 mm in height (subclass
a), since this condition is crucial for allowing flap advance-
ment. In this class it is not necessary to remove the implant-
supported crown.
While in a Class II, if at least one papilla is<3 mm in height
(subclass b), it is necessary to remove the implant-supported
crown, modify/change the abutment in order to improve the
weak papilla and a combined prosthetic-surgical approach is
recommended29 (Fig. 5).
When the height of at least one papilla is at the same level
of or more apical to the ideal position of the soft tissue mar-
gin of the implant-supported crown (subclass c), the implant
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F I G U R E 2 Frontal (top), occlusal view (middle), and schematic drawings (before and after crown removal) (bottom) of PSTD class III. This
class is characterized by a soft tissue margin which is located more apical to the ideal position of the gingival margin and the implant-supported
crown profile is located outside the imaginary curve line that connects the profile of the adjacent teeth at the level of the soft tissue margin. In
addition, the head of the implant, evaluated after crown removal, is inside the straight imaginary line that connects the profile of the adjacent teeth at
the level of the gingival margin
supported crown must be removed, a healing cap must be
applied, and a soft tissue augmentation procedure with a sub-
merged healing is recommended.
Given the position of the papillae that allow for flap
advancement and coronal suturing, Class IIIa can be treated
with CAF + CTG after implant supported crown removal
without the need to change the abutment and wait for the
improvement of the papillae.
Conversely, a complete prosthetic-surgical approach is rec-
ommended for treating a Class IIIb.
The lack of at least one papilla in Class IIIc requires a soft
tissue augmentation procedure with submerged healing.
When sufficient height (≥3 mm) of both papillae is asso-
ciated with buccal malpositioning of the implant head (Class
IV a) a prosthetic surgical approach is suggested.
Finally, a PSTD of Class IVb can be managed with a
soft tissue augmentation procedure with a submerged healing,
while PSTDs of Class IV c requires implant removal.31
Table 1 summarizes the proposal treatment approaches for
each PSTD class.
4 DISCUSSION
The efficacy of root coverage procedures in treating gingi-
val recessions on natural dentition have been well establi-
shed.32,33 Additionally, the position of the interproximal
attachment levels as the main limiting factor in the amount of
root coverage that can be achieved, has also been confirmed.21
A PSTD around implants differs greatly from a gingival
recession on natural teeth. Incorrect implant placement, lack
of buccal bone or mucosal thickness, improper case selection
for immediate implant placement, and diameter of the implant
platform, act as predisposing factors specifically leading to
a mucosal recessions on implants.6 Additionally, the vascu-
larization and composition of the connective tissue around
implants (with fibers parallel to the implant surface) that
resembles a scar tissue,18 may negatively impact the surgical
outcomes. It may be assumed that the etiology of the PSTD
along with the peri-implant anatomy are the main reasons
for the overall low predictability of the traditional surgical
approach for treating these mucosal defects.19,22
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F I G U R E 3 Frontal (A), occlusal view (B and C) and schematic drawings (before and after crown removal) (D and E) of PSTD Class IV. This
class has similarities with PSTD Class III in terms of gingival margin position; however the head of the implant, evaluated after crown removal, is
outside the straight imaginary line that connects the profile of the adjacent teeth at the level of the gingival margin
F I G U R E 4 Peri-implant soft tissue dehiscence/deficiency (PSTD) subclasses based on the height of the papillae. A) Subclass a. The tip of
both papillae is ≥3 mm coronal to the ideal position of soft tissue margin of the implant-supported crown. B) Subclass b. The tip of at least one
papilla is at a distance <3 mm coronal to the ideal position of the soft tissue margin of the implant supported crown. C) Subclass c. The height of at
least one papilla is at the same level or more apical of the ideal position of the soft tissue margin of the implant-supported crown
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T A B L E 1 Classification of peri-implant soft tissue dehiscence/deficiencies (PSTD) and recommended surgical treatment
Class Peri-implant soft tissue dehiscence/deficiency characteristics Recommended surgical treatment
I The soft tissue margin is located at the same level of the ideal position
of the gingival margin of the homologous natural tooth, and the
color of the abutment/implant is visible only through the mucosa
and/or there is a lack of keratinized tissue/soft tissue thickness
Ia: CAF or tunnel + CTG (or other graft substitutes)
Ib: Combined prosthetic-surgical approach
II The soft tissue margin is located more apical to the ideal position of the
gingival margin of the homologous natural tooth, and the
implant-supported crown profile is located inside (more palatal) the
imaginary curve line that connects the profile of the adjacent teeth at
the level of the soft tissue margin
IIa: No crown removal, CAF + CTG
IIb: Combined prosthetic-surgical approach
IIc: Soft tissue augmentation with submerged
healing
III The soft tissue margin is located more apical to the ideal position of the
gingival margin of the homologous natural tooth
The implant-supported crown profile is located outside (more
facially) the imaginary curve line that connects the profile of the
adjacent teeth at the level of the soft tissue margin, and the head of
the implant (evaluated by removing the crown) is inside (more
palatally) the imaginary straight line connecting the profile of the
adjacent teeth at the level of the soft tissue margin
IIIa: Crown removal, CAF + CTG
IIIb: Combined prosthetic-surgical approach
IIIc: Soft tissue augmentation with submerged
healing
IV The soft tissue margin is located more apical with respect of the ideal
position of the gingival margin of the homologous natural tooth
The implant-supported crown profile is located outside (more
facially) the imaginary curve line that connects the profile of the
adjacent teeth at the level of the soft tissue margin, and the head of
the implant (evaluated by removing the crown) is outside (more
facially) the imaginary straight line connecting the profile of the
adjacent teeth at the level of the soft tissue margin
IVa: Combined prosthetic-surgical approach




a The tip of both papillae is ≥3 mm coronal to the ideal position of soft
tissue margin of the implant-supported crown
b The tip of at least one papilla is ≥1 mm but <3 mm coronal to the ideal
position of the soft tissue margin of the implant supported crown
c* The height of at least one papilla is <1 mm coronal to the ideal position
of the soft tissue margin of the implant-supported crown
*Does not apply for class I PSTD
Given the variety of factors that can cause a PSTD, a thor-
ough pre-operatory case assessment is crucial. However, to
date guidelines for defining PSTDs are scarce in the litera-
ture. A prognostic classification that included systemic and
local factors, as well as implant/host relationship, was pro-
posed by Decker et al.34 However, no clinical recommenda-
tions in regard to treatment of the PSTDs were provided.
The present classification identifies four classes of PSTDs
based on the bucco-lingual position of the crown/implant
(except for class I which is characterized by inadequate peri-
implant keratinized tissue/soft tissue thickness) and three sub-
categories (for Class II, III, and IV) according to the interprox-
imal papillae dimension. Indeed, recently the quality and the
dimensions of the papillae and the bucco-lingual position of
the implant have been recognized as key factors affecting the
treatment approach.6
It should be noted that in Class III and IV, where the crown
is located more facially and outside the imaginary line con-
necting the profile of the adjacent teeth at the level of the soft
tissue margin, the position of the implant head must be evalu-
ated. This can only be performed after removing the implant-
supported crown, which is a fundamental step in the treatment
of such conditions.6
A Bilaminar technique35 or a tunneling approach23 with the
implant supported crown in situ, is recommended in treating a
Class I PSTD, characterized by the appearance of the implant
components underneath the buccal soft tissue. For both tech-
niques a minimal coronal advancement of the flap is indicated
to compensate for the space occupied by the graft/substitute
material. It has been shown that soft tissue thickness is a cru-
cial factor in discoloration of the mucosa36 and that a min-
imum of 2 mm in thickness is necessary to mask the grey-
ish color of the implant components.37 The gold standard
for increasing soft tissue thickness is the autologous CTG. In
particular, because of its composition (dense connective tissue
rich of collagen fibers with low amount of fatty and glandular
tissue) and its characteristics (stability and firmness), the CTG
derived from the de-epithelialization of a free gingival graft
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F I G U R E 5 Combined prosthetic-surgical approach for the treatment of a PSTD Class II subclass b. A Baseline frontal and B occlusal pictures.
C Frontal and D, occlusal pictures at the end of the presurgical prosthetic treatment: note the increase of the interproximal soft tissues. Surgical
procedure: E trapezoidal shape flap elevation and F connective tissue graft (CTG) fixation at the level of the gingival margin of the contralateral
homologous tooth. Note the de-epithelialization of the anatomic papillae toward the palatal aspect. G Coronally advanced flap (CAF) closure and H
occlusal pictures showing the primary intention wound closure and the flap adaptation above the abutment convexity. I Frontal and J occlusal
pictures showing soft tissue maturation before conditioning phase. K Frontal and L occlusal pictures after definitive restoration demonstrating the
complete dehiscence coverage and the increase in soft tissue thickness
can be considered the material of choice.38 Alternatively, graft
substitutes, such as collagen or acellular dermal matrices have
also been used for increasing the tissue thickness with promis-
ing results.22,39 In the presence of weak papillae, despite the
correct position of the gingival margin (Class Ib), increasing
the interproximal soft tissue though crown removal and abut-
ment reduction is strongly suggested.
Managing Class II defects, when the tips of both papillae
are at least 3 mm coronal to the ideal position of soft tissue
margin of the implant-supported crown (subclass a), CAF +
CTG is the treatment of choice, either performed with19,22 or
without40 vertical releasing incisions. In this clinical situation
it is even more recommended to use a CTG derived from the
de-epithelialization of a free gingival graft.
The only difference is that in Class II, in the presence of
adequate papillae dimension, the surgical treatment can be
performed with the implant supported crown in situ while
in Class III and IV it is necessary to remove the crown and
perform the surgery on the abutment. In a Class IV it is sug-
gested to perform the entire prosthetic surgical technique.
The prosthetic-surgical technique introduced by Zucchelli
and coworkers29 is indicated for the treatment of the PSTDs
with a minor interproximal bone loss and shallow papillae
(subcategory b). This approach involves crown removal,
change, or reduction of the abutment, providing shorter
provisional crowns 2 months before the surgery to allow for
maximum interproximal soft tissue growth in width and thick-
ness. In this way the CAF + CTG can be performed by taking
advantage of the augmented interproximal papillae that can be
de-epithelialized on the occlusal surface towards the palate.
After maturation and conditioning of the increased soft tissue
with a new temporary crown, the definitive restoration can be
provided 8 to 12 months after the surgery. This protocol has
shown to be highly successful in treating STDs both in the
short- and long-term29,38 with a mean dehiscence coverage of
96.3% and 99.2%, at 1 and 5 years, respectively. The stability
and the improvement in mean coverage is most likely due
to the CTG maturation with time that results in an increased
buccal soft tissue thickness (1.54 ± 0.21 mm at 1 year and 1.8
at 5 years). Additionally, the phenomenon of “creeping” may
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explain the improved mean coverage of the dehiscence at
5 years compared with the 1-year time point.38 The stability
in the long-term results, together with the possibility of
having a coronal migration of the soft tissue margin, further
supports the benefits of using a CTG de-epithelialized from
the palatal free gingival graft for the treatment of the PSTD.
When the height of at least one papilla is at the same level
or more apical of the ideal position of the soft tissue margin
of the implant-supported crown (subclass c), it is crucial to
consider the position of the head of the implant with respect
to the imaginary line connecting the adjacent gingival margin.
Indeed, an implant head position within this line (Class IIIc)
can be treated with a submerged approach.27,28 The goal of the
surgery, in this case, is not only to cover the PSTD but also
to improve the height of the deficient papilla/ae. The ratio-
nale behind this approach is to leave the soft tissue to cover
the head of the implant as much as possible by removing the
crown and the abutment and leaving only the cover screw.
After 3 to 6 months, during which the patient is wearing a tem-
porary Maryland bridge, the implant site can then be treated
as an edentulous area with a soft tissue augmentation proce-
dure and submerged healing. After the healing (6 months) a
punch flapless procedure is used to expose the implant head,
and subsequent to conditioning the augmented peri-implant
soft tissue with a new temporary crown the final restoration is
delivered.28 Among these procedures, the connective tissue
platform technique has also been demonstrated to be effec-
tive in increasing both the apical-coronal and bucco-lingual
dimensions of the soft tissue in a single edentulous area in
one surgical procedure.6,41
Implant removal should be considered when, together with
the lack of papilla/ae, the implant head is buccally displaced
(Class IVc).31 Indeed, given the implant malpositioning, it is
very likely that a Class IVc PSTD is also complicated by a
deep buccal bone dehiscence that negatively affects the main-
tenance of the soft-tissue margins6 and therefore can nega-
tively impair the outcomes of the surgery.
Bearing in mind that the treatment of PSTD is mainly
guided by the patients’ esthetic demands and that the final
outcome is not only a complete dehiscence coverage but also
a satisfactory esthetic outcome, the present article provides a
classification of PSTDs strictly related to the possible surgi-
cal approaches for managing these complications. However,
it should be mentioned that this classification is based on the
clinical experience of the authors and therefore, future studies
are needed to validate this proposal.
5 CONCLUSIONS
The proposed classification describes four classes and three
subcategories of soft tissue dehiscence/deficiencies at sin-
gle implant sites based on the bucco-lingual position of the
implant-supported crown (and the implant head) as well as the
interproximal soft tissue dimensions and provides recommen-
dations for selecting the most appropriate treatment protocol.
Further studies are necessary to explore its validity.
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